NATCO Pharma Competitors and Similar CompaniesClear all

NATCO Pharma's competitors and similar companies include Syngene International, Siegfried and CHUGAI PHARMA FRANCE.

	NATCO Pharma NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).	Syngene International Syngene International is integrated research, development, and manufacturing company providing scientific services.	Siegfried Siegfried Holding is a company that develops and manufactures drug substances and products.	CHUGAI PHARMA FRANCE CHUGAI PHARMA FRANCE is a company that specializes in pharmaceutical products.
Founding Date	Founding Date 1981	Founding Date 1993	Founding Date 1873	Founding Date 1998
Type	Type Public	Type Public	Type Public	Type Subsidiary
Tags	Tags Healthcare drug development oncology pharma	Tags Manufacturing & Industrial biotech clinical research contractor drug development	Tags Manufacturing & Industrial biotech drug development pharma	Tags Healthcare drug development oncology pharma
Locations	Locations Hyderabad, IN HQ Central Hope Town, IN Chennai, IN Hyderabad, IN Santola, IN Vijayapuri North, IN	Locations Bangalore, IN HQ Bangalore, IN Bengaluru, IN	Locations Zofingen, CH HQ Nantong, CN Saint Vulbas, FR Hameln, DE Minden, DE Birżebbuġa, MT Barberà Del Vallès, ES see more	Locations Paris, FR HQ
Employees	Employees 4,016	Employees 6,510	Employees 3,886	Employees 73
Financial
Revenue (est.)	Revenue (est.) ₹40.8b (FY, 2026)	Revenue (est.) ₹37.4b (FY, 2026)	Revenue (est.) CHF1.3b (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods ₹6.9b (FY, 2026)	Cost of goods ₹9.2b (FY, 2026)	Cost of goods CHF879.1m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit ₹36.9b (FY, 2026)	Gross profit ₹28.9b (FY, 2026)	Gross profit CHF463.5m (FY, 2025)	Gross profit N/A
Net income	Net income ₹13.7b (FY, 2026)	Net income ₹3.2b (FY, 2026)	Net income CHF168.4m (FY, 2025)	Net income N/A